Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

15. April 2026 08:00 ET | Quelle: Filana Therapeutics, Inc.

Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data

Study in a well-accepted mouse model of severe Tuberous Sclerosis Complex (TSC) showed that simufilam attenuated the progression of seizures in a dose-dependent mannerResults confirm and extend...
15. April 2026 08:00 ET | Quelle: Achieve Life Sciences

Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions

Adare Partnership Provides Supply Chain Redundancy and U.S.-based Manufacturing Capability Company Reiterates Guidance - If Approved, Cytisinicline Commercial Launch Expected in First Half of 2027 ...
15. April 2026 07:00 ET | Quelle: Cibus US LLC

Cibus Announces the Election of Thomas Urban to Board of Directors

SAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed...
15. April 2026 07:00 ET | Quelle: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications

Dr. Dennis K. McBride, PhD (CAPT, Medical Service Corps, US Navy, Ret., Distinguished Research Fellow, National Defense University, and former senior executive, Office Secretary of Defense) to serve...
14. April 2026 14:09 ET | Quelle: Toll Brothers, Inc.

Toll Brothers at Midline Now Open in Webster, Texas

WEBSTER, Texas, April 14, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest Houston-area community, Toll Brothers at...
14. April 2026 09:15 ET | Quelle: Myriad Genetics, Inc.

Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan

SALT LAKE CITY, April 14, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Japan’s Ministry of...
14. April 2026 08:30 ET | Quelle: TOMI Environmental Solutions, Inc.

TOMI Reports Strong Q1 2026 Sales of High-Margin BIT Solution, Indicating Positive Growth Trends

FREDERICK, Md., April 14, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection/decontamination solutions, reports preliminary...
14. April 2026 08:15 ET | Quelle: ZenaTech Inc.

ZenaTech Completes Acquisition of NOW Solutions Inc., Expanding its Enterprise SaaS Division with Government and Public Sector Customers and Strengthening Recurring Revenue Growth

VANCOUVER, British Columbia, April 14, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology solution provider specializing in AI (Artificial...
14. April 2026 08:05 ET | Quelle: NAPC Defense, Inc.

NAPC Defense Invites Shareholders and Investors to June 30, 2026 Company Meet & Greet in Reno

NAPC Defense (OTCID: BLIS) to host Company Shareholder Meet & Greet on June 30, 2026, in Reno, Nevada
14. April 2026 07:45 ET | Quelle: AVITA Medical

AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting

Cohealyx interim data show ~20-day reduction in time to graft vs benchmark, with strong investigator satisfaction and consistent performance across wounds.

Vorherige Seite

Nächste Seite